Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. (Q51545120)

6 April 2018

title

Resistance is futile: the bacteriocin model for addressing the antibiotic resistance challenge. (English)

1 reference

6 April 2018

main subject

antibiotic resistance

1 reference

Margaret A Riley

1

1 reference

6 April 2018

Sandra M Robinson

2

1 reference

6 April 2018

Christopher M Roy

3

1 reference

6 April 2018

Morgan Dennis

4

1 reference

6 April 2018

Vivian Liu

5

1 reference

6 April 2018

Robert L Dorit

6

1 reference

6 April 2018

publication date

1 December 2012

1 reference

6 April 2018

Biochemical Society Transactions

published in

1 reference

6 April 2018

volume

40

1 reference

6 April 2018

issue

6

1 reference

6 April 2018

page(s)

1438-1442

1 reference

6 April 2018

Tackling antibiotic resistance

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Antibacterial resistance worldwide: causes, challenges and responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Bacterial resistance: origins, epidemiology, and impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Antibiotic-resistant bugs in the 21st century--a clinical super-challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Antibiotics for emerging pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Fighting bacterial resistance at the root: need for adapted EMEA guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Antimicrobial stewardship: bridging the gap between quality care and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

A phylogenetic approach to assessing the targets of microbial warfare

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Bacteriocins: evolution, ecology, and application

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

The impact of antibiotic use on resistance development and persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Urinary tract infections: disease panorama and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Efficacy and safety profile of long-term nitrofurantoin in urinary infections: 18 years' experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Pathogenesis of urinary tract infections: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Diagnosis and treatment of uncomplicated urinary tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

21 January 2018

Antibiotic armageddon

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Fluoroquinolone-resistant urinary isolates of Escherichia coli from outpatients are frequently multidrug resistant: results from the North American Urinary Tract Infection Collaborative Alliance-Quinolone Resistance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Bacterial biofilms in patients with indwelling urinary catheters

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Trends in antimicrobial resistance among urinary tract infection isolates of Escherichia coli from female outpatients in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Increasing resistance to trimethoprim-sulfamethoxazole among isolates of Escherichia coli in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Treatment of uncomplicated urinary tract infections in an era of increasing antimicrobial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Management of urinary tract infections: historical perspective and current strategies: Part 1--Before antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections, in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Activity of pyocin S2 against Pseudomonas aeruginosa biofilms

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Prevention of catheter-associated urinary tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

The management of urinary infections; what have we learned in the past decade?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

Epidemiology of urinary tract infections: Incidence, morbidity, and economic costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBST20120179

21 January 2018

Identifiers

DOI

10.1042/BST20120179

1 reference

6 April 2018

1 reference

6 April 2018